The Current Evidence Levels for Biofeedback and Neurofeedback Interventions in Treating Depression: A Narrative Review

Overview

Journal Neural Plast

Specialty Neurology

Date 2021 Feb 22

PMID 33613671

Citations 10

Authors

Mikhail Ye Melnikov

Affiliations

Soon will be listed here.

Abstract

This article is aimed at showing the current level of evidence for the usage of biofeedback and neurofeedback to treat depression along with a detailed review of the studies in the field and a discussion of rationale for utilizing each protocol. La Vaque et al. criteria endorsed by the Association for Applied Psychophysiology and Biofeedback and International Society for Neuroregulation & Research were accepted as a means of study evaluation. Heart rate variability (HRV) biofeedback was found to be moderately supportable as a treatment of MDD while outcome measure was a subjective questionnaire like Beck Depression Inventory (level 3/5, "probably efficacious"). Electroencephalographic (EEG) neurofeedback protocols, namely, alpha-theta, alpha, and sensorimotor rhythm upregulation, all qualify for level 2/5, "possibly efficacious." Frontal alpha asymmetry protocol also received limited evidence of effect in depression (level 2/5, "possibly efficacious"). Finally, the two most influential real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback protocols targeting the amygdala and the frontal cortices both demonstrate some effectiveness, though lack replications (level 2/5, "possibly efficacious"). Thus, neurofeedback specifically targeting depression is moderately supported by existing studies (all fit level 2/5, "possibly efficacious"). The greatest complication preventing certain protocols from reaching higher evidence levels is a relatively high number of uncontrolled studies and an absence of accurate replications arising from the heterogeneity in protocol details, course lengths, measures of improvement, control conditions, and sample characteristics.

Citing Articles

Decoded EEG neurofeedback-guided cognitive reappraisal training for emotion regulation.

Li L, Gui X, Huang G, Zhang L, Wan F, Han X Cogn Neurodyn. 2024; 18(5):2659-2673.

PMID: 39555250 PMC: 11564442. DOI: 10.1007/s11571-024-10108-x.

Reinforcement learning processes as forecasters of depression remission.

Bansal V, McCurry K, Lisinski J, Kim D, Goyal S, Wang J J Affect Disord. 2024; 368:829-837.

PMID: 39271064 PMC: 11573115. DOI: 10.1016/j.jad.2024.09.066.

Multimodal and hemispheric graph-theoretical brain network predictors of learning efficacy for frontal alpha asymmetry neurofeedback.

Li L, Li Y, Li Z, Huang G, Liang Z, Zhang L Cogn Neurodyn. 2024; 18(3):847-862.

PMID: 38826665 PMC: 11143167. DOI: 10.1007/s11571-023-09939-x.

Mapping the evolution of neurofeedback research: a bibliometric analysis of trends and future directions.

Wider W, Mutang J, Chua B, Pang N, Jiang L, Fauzi M Front Hum Neurosci. 2024; 18:1339444.

PMID: 38799297 PMC: 11116792. DOI: 10.3389/fnhum.2024.1339444.

Study of electronic biofeedback combined with nursing intervention in the treatment of vascular cognitive impairment-no dementia.

Wang H, Zhang X, Wang P, Dai G, Liu L, Xu Y Acta Neurol Belg. 2024; 124(3):871-877.

PMID: 38285160 DOI: 10.1007/s13760-023-02471-z.

References

Tsuchiyagaito A, Misaki M, Al Zoubi O, Paulus M, Bodurka J . Prevent breaking bad: A proof of concept study of rebalancing the brain's rumination circuit with real-time fMRI functional connectivity neurofeedback. Hum Brain Mapp. 2020; 42(4):922-940. PMC: 7856643. DOI: 10.1002/hbm.25268. View

Climov D, Lysy C, Berteau S, Dutrannois J, Dereppe H, Brohet C . Biofeedback on heart rate variability in cardiac rehabilitation: practical feasibility and psycho-physiological effects. Acta Cardiol. 2014; 69(3):299-307. DOI: 10.1080/ac.69.3.3027833. View

Sitaram R, Ros T, Stoeckel L, Haller S, Scharnowski F, Lewis-Peacock J . Closed-loop brain training: the science of neurofeedback. Nat Rev Neurosci. 2016; 18(2):86-100. DOI: 10.1038/nrn.2016.164. View

Zotev V, Krueger F, Phillips R, Alvarez R, Simmons W, Bellgowan P . Self-regulation of amygdala activation using real-time FMRI neurofeedback. PLoS One. 2011; 6(9):e24522. PMC: 3169601. DOI: 10.1371/journal.pone.0024522. View

Caldwell Y, Steffen P . Adding HRV biofeedback to psychotherapy increases heart rate variability and improves the treatment of major depressive disorder. Int J Psychophysiol. 2018; 131:96-101. DOI: 10.1016/j.ijpsycho.2018.01.001. View

Linden D . Neurofeedback and networks of depression. Dialogues Clin Neurosci. 2014; 16(1):103-12. PMC: 3984886. View

Kudo N, Shinohara H, Kodama H . Heart rate variability biofeedback intervention for reduction of psychological stress during the early postpartum period. Appl Psychophysiol Biofeedback. 2014; 39(3-4):203-11. PMC: 4220117. DOI: 10.1007/s10484-014-9259-4. View

McCraty R, Atkinson M, Lipsenthal L, Arguelles L . New hope for correctional officers: an innovative program for reducing stress and health risks. Appl Psychophysiol Biofeedback. 2009; 34(4):251-72. DOI: 10.1007/s10484-009-9087-0. View

Servant D, Logier R, Mouster Y, GOUDEMAND M . [Heart rate variability. Applications in psychiatry]. Encephale. 2009; 35(5):423-8. DOI: 10.1016/j.encep.2008.06.016. View

10.

Lande R, Williams L, Francis J, Gragnani C, Morin M . Efficacy of biofeedback for post-traumatic stress disorder. Complement Ther Med. 2010; 18(6):256-9. DOI: 10.1016/j.ctim.2010.08.004. View

11.

Markiewcz R . The use of EEG Biofeedback/Neurofeedback in psychiatric rehabilitation. Psychiatr Pol. 2018; 51(6):1095-1106. DOI: 10.12740/PP/68919. View

12.

Schoenberg P, David A . Biofeedback for psychiatric disorders: a systematic review. Appl Psychophysiol Biofeedback. 2014; 39(2):109-35. DOI: 10.1007/s10484-014-9246-9. View

13.

Greenberg D, Rice H, Cooper J, Cabeza R, Rubin D, LaBar K . Co-activation of the amygdala, hippocampus and inferior frontal gyrus during autobiographical memory retrieval. Neuropsychologia. 2005; 43(5):659-74. DOI: 10.1016/j.neuropsychologia.2004.09.002. View

14.

Nolan R, Kamath M, Floras J, Stanley J, Pang C, Picton P . Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control. Am Heart J. 2005; 149(6):1137. DOI: 10.1016/j.ahj.2005.03.015. View

15.

Choi S, Chi S, Chung S, Kim J, Ahn C, Kim H . Is alpha wave neurofeedback effective with randomized clinical trials in depression? A pilot study. Neuropsychobiology. 2010; 63(1):43-51. DOI: 10.1159/000322290. View

16.

Mehler D, Sokunbi M, Habes I, Barawi K, Subramanian L, Range M . Targeting the affective brain-a randomized controlled trial of real-time fMRI neurofeedback in patients with depression. Neuropsychopharmacology. 2018; 43(13):2578-2585. PMC: 6186421. DOI: 10.1038/s41386-018-0126-5. View

17.

Nestoriuc Y, Rief W, Martin A . Meta-analysis of biofeedback for tension-type headache: efficacy, specificity, and treatment moderators. J Consult Clin Psychol. 2008; 76(3):379-96. DOI: 10.1037/0022-006X.76.3.379. View

18.

Di G, Wu S . Emotion recognition from sound stimuli based on back-propagation neural networks and electroencephalograms. J Acoust Soc Am. 2015; 138(2):994-1002. DOI: 10.1121/1.4927693. View

19.

Karavidas M, Lehrer P, Vaschillo E, Vaschillo B, Marin H, Buyske S . Preliminary results of an open label study of heart rate variability biofeedback for the treatment of major depression. Appl Psychophysiol Biofeedback. 2007; 32(1):19-30. DOI: 10.1007/s10484-006-9029-z. View

20.

Mennen A, Norman K, Turk-Browne N . Attentional bias in depression: understanding mechanisms to improve training and treatment. Curr Opin Psychol. 2019; 29:266-273. PMC: 6980447. DOI: 10.1016/j.copsyc.2019.07.036. View